Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Screening and Brief Advice to Reduce Teen Substance Use

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00227877
Recruitment Status : Completed
First Posted : September 28, 2005
Results First Posted : September 21, 2018
Last Update Posted : September 21, 2018
Sponsor:
Collaborators:
Cambridge Health Alliance
Concord Hospital
Fallon Clinic
Tufts Medical Center
University of Vermont
Information provided by (Responsible Party):
John R Knight, MD, Boston Children’s Hospital

Brief Summary:

The purpose of this study is to test the effectiveness of a brief intervention for alcohol and drug use in adolescents that a primary care doctor can give in his/her office. The study will be conducted in nine primary care offices in three New England states, and in ten pediatric offices in Prague, Czech Republic (CZR).

We hypothesize that:

  1. Among 12-18 year old well care patients who screen positive for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing drug and alcohol use;
  2. Among 12-18 year old well care patients who screen negative for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing initiation of drug and alcohol use as measured by self-reports of substance use;
  3. Among 12-18 year old well care patients who are at risk for driving/riding while impaired (DRWI), the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing DRWI risk behavior as measured by a standardized scale.

Condition or disease Intervention/treatment Phase
Substance Related Disorders Behavioral: cSBA - New England Behavioral: cSBA - Czech Republic Not Applicable

Detailed Description:

We are trying to find out the best way for doctors to talk with their adolescent patients about alcohol and drug use. Adolescents 12-18 who are coming to their doctor's office for a routine well-care or follow-up visit will be invited to participate in the study. Participants do not have to have ever used alcohol or drugs. All participants will answer a computerized questionnaire about alcohol and drug use three times. The first one will be at the time of a doctor's visit. The second time will be three months later and the third time a year later. Adolescents who agree to be in the study during the first year will be in the 'control' group. Their doctor will talk to them about drugs and alcohol the same as he/she usually does for all his/her patients. Those who agree to be in the study during the second year will be in the 'intervention' group. Everyone in the 'intervention' group will receive some advice on the computer about their alcohol and drug use. Their doctor will also give them some specific advice about drug and alcohol use. The researchers have chosen what that advice will be, and all doctors involved in the study will give advice according to the study protocol. Participants and their parents will also be given educational information about alcohol and drugs. We will test the effectiveness of the intervention by comparing drug and alcohol use between those who are in the 'control' group, and those who are in the 'intervention' group.

We we will also validate the Czech version of the CRAFFT screen before conducting the effectiveness trial outlined above in the Czech Republic.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 2695 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: In this before-/after- quasi-experimental trial, all sites first completed a treatment-as-usual phase with assessments only, followed by all sites undergoing training and completing a subsequent intervention phase.
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Screening and Brief Advice to Reduce Teen Substance Use
Actual Study Start Date : December 2005
Actual Primary Completion Date : December 2008
Actual Study Completion Date : February 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Drug Abuse

Arm Intervention/treatment
No Intervention: Control - New England
Control participants will receive "care as usual" from their provider
Experimental: cSBA - New England
Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking points" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use.
Behavioral: cSBA - New England
Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking point" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use.
Other Name: SBIRT

No Intervention: Control - Czech Republic
Control participants will receive "care as usual" from their provider
Experimental: cSBA - Czech Republic
Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking points" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use.
Behavioral: cSBA - Czech Republic
Participants who are in the experimental arm will complete the CRAFFT screen on the computer and receive information on the computer regarding the health effects of substance use. Their provider will be given the results of their CRAFFT screen and a list of suggested "talking point" which they will use to guide a discussion with the patient about drug and alcohol use. Participants and their families will also receive educational brochures about substance use.
Other Name: SBIRT




Primary Outcome Measures :
  1. Past-90-day Substance Use at 3 Months Among Baseline Substance Users - New England [ Time Frame: Past-90-days at 3 months post-baseline ]
    Of those participants who reported past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 3 months post-baseline assessment in New England, USA

  2. Past-90-day Substance Use at 3 Months Among Baseline Substance Non-Users, New England [ Time Frame: Past-90-days at 3 months post-baseline ]
    Of those participants who reported NO past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 3 months post-baseline assessment in New England, USA

  3. Past-12-month Substance Use at 12 Months Among Baseline Substance Users, New England [ Time Frame: Past-12-months at 12 months post-baseline ]
    Of those participants who reported past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 12 months post-baseline assessment in New England, USA

  4. Past-12-month Substance Use at 12 Months, Baseline Substance Non-Users, New England [ Time Frame: Past-12-months at 12 months post-baseline ]
    Of those participants who reported NO past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 12 months post-baseline assessment in New England, USA

  5. Past-90-day Substance Use at 3 Months Among Baseline Substance Users - Prague [ Time Frame: Past-90-days at 3 months post-baseline ]
    Of those participants who reported past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 3 months post-baseline assessment in Prague, Czech Republic

  6. Past-90-day Substance Use at 3 Months Among Baseline Substance Non-Users - Prague, CZ [ Time Frame: Past-90-days at 3 months post-baseline ]
    Of those participants who reported NO past-12-month drug or alcohol use at baseline,the number reporting past-90-day drug or alcohol use at 3 months post-baseline assessment in Prague, Czech Republic

  7. Past-12-Month Substance Use at 12 Months Among Baseline Substance Users - Prague, CZ [ Time Frame: Past-12-months at 12 months post-baseline ]
    Of those participants who reported past-12-month drug or alcohol use at baseline,the number reporting past-12-month drug or alcohol use at 12 months post-baseline assessment in Prague, Czech Republic

  8. Past-12-Month Substance Use at 12 Months Among Baseline Substance Non-Users - Prague, CZ [ Time Frame: Past-12-months at 12 months post-baseline ]
    Of those participants who reported past-12-month drug or alcohol use at baseline,the number reporting past-12-month drug or alcohol use at 12 months post-baseline assessment in Prague, Czech Republic


Secondary Outcome Measures :
  1. Any Risky DRWI at 3 Months - New England [ Time Frame: Past-90-days at 3 months post-baseline ]
    Any past-90-day reported Riding with a driver who had used alcohol or other drugs or Driving after having used alcohol or other drugs (DRWI) at 3 months post-baseline assessment - New England

  2. Any Risky DRWI at 12 Months - New England [ Time Frame: Past-90-days at 12 months post-baseline ]
    Any past-90-day reported Riding with a driver who had used alcohol or other drugs or Driving after having used alcohol or other drugs (DRWI) at 12 months post-baseline assessment - New England

  3. Any Risky DRWI at 3 Months - Prague, CZR [ Time Frame: Past-90-days at 3 months post-baseline ]
    Any past-90-day reported Riding with a driver who had used alcohol or other drugs or Driving after having used alcohol or other drugs (DRWI) at 3 months post-baseline assessment - Prague, Czech Republic

  4. Any Risky DRWI at 12 Months - Prague, CZR [ Time Frame: Past-90-days at 12 months post-baseline ]
    Any past-90-day reported Riding with a driver who had used alcohol or other drugs or Driving after having used alcohol or other drugs (DRWI) at 12 months post-baseline assessment - Prague, Czech Republic



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   12 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

12-18 year old patients coming for well care or follow-up visits to one of the study sites, All levels of substance use, Able to read and understand English

Exclusion Criteria:

Will not be available for 12 month follow-up period, Medically unstable at the time of the visit


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00227877


Locations
Layout table for location information
United States, Massachusetts
Tufts-New England Medical Center
Boston, Massachusetts, United States, 02111
Cambridge Pediatrics
Cambridge, Massachusetts, United States, 02139
Fallon Clinic
Worcester, Massachusetts, United States, 01605
United States, New Hampshire
Capital Region Family Health Center
Concord, New Hampshire, United States, 03301
United States, Vermont
Milton Family Practice
Milton, Vermont, United States, 05468
Czechia
Center for the Evaluation, Prevention, and Research of Substance Abuse
Prague, Czechia
Sponsors and Collaborators
Boston Children’s Hospital
Cambridge Health Alliance
Concord Hospital
Fallon Clinic
Tufts Medical Center
University of Vermont
Investigators
Layout table for investigator information
Principal Investigator: John R Knight, M.D. Boston Children’s Hospital

Additional Information:
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: John R Knight, MD, Associate Professor of Pediatrics, Harvard Medical School, Boston Children’s Hospital
ClinicalTrials.gov Identifier: NCT00227877     History of Changes
Obsolete Identifiers: NCT00592878, NCT00592956
Other Study ID Numbers: NIDA-R01DA0118848
First Posted: September 28, 2005    Key Record Dates
Results First Posted: September 21, 2018
Last Update Posted: September 21, 2018
Last Verified: December 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by John R Knight, MD, Boston Children’s Hospital:
alcohol abuse
substance abuse
substance related disorders

Additional relevant MeSH terms:
Layout table for MeSH terms
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Ethanol
Anti-Infective Agents, Local
Anti-Infective Agents
Central Nervous System Depressants
Physiological Effects of Drugs